1. |
Guo Y, Liu S, Wang P, et al. Granulocyte colony-stimulating factor improves neuron survival in experimental spinal cord injury by regulating nucleophosmin-1 expression. J Neurosci Res, 2014, 92(6): 751-760.
|
2. |
Chen WF, Chen CH, Chen NF, et al. Neuroprotective effects of direct intrathecal administration of granulocyte colony-stimulating factor in rats with spinal cord injury. CNS Neurosci Ther, 2015, 21(9): 698-707.
|
3. |
Kadota R, Koda M, Kawabe J, et al. Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats. PLoS One, 2012, 7(11): e50391.
|
4. |
Takahashi H, Yamazaki M, Okawa A, et al. Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase Ⅰ/Ⅱa clinical trial. Eur Spine J, 2012, 21(12): 2580-2587.
|
5. |
李晓飞, 文益民, 张增山, 等. 骨髓基质干细胞移植联合应用 G-CSF 对大鼠脊髓损伤修复的影响. 中国矫形外科杂志, 2010, 18(17): 1457-1462.
|
6. |
Hibbert B, Hayley B, Beanlands RS, et al. Granulocyte colony-stimulating factor therapy for stem cell mobilization following anterior wall myocardial infarction: the CAPITAL STEM MI randomized trial. CMAJ, 2014, 186(11): E427-E434.
|
7. |
梁少兰, 杜作义, 李自成, 等. 粒细胞集落刺激因子动员内皮祖细胞对心肌梗死患者心功能的影响. 实用医学杂志, 2014, 30(17): 2759-2761.
|
8. |
Shyu WC, Lin SZ, Lee CC, et al. Granulocyte colony-stimulating factor foracute ischemic stroke: arandomized controlled trial. CMAJ, 2006, 174(7): 927-933.
|
9. |
Nefussy B, Artamonov I, Deutsch V, et al. Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study. Amyotroph Lateral Scler, 2010, 11(1-2): 187-193.
|
10. |
Ito Y, Sugimoto Y, Tomioka M, et al. Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: a prospective study about neurological recovery and early complications Spine (Phila Pa 1976), 2009, 34(20): 2121-2124.
|
11. |
Matsumoto T, Tamaki T, Kawakami M, et al. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine (Phila Pa 1976), 2001, 26(4): 426-430.
|
12. |
杨瑞瑞, 邓宇斌. 干细胞修复脊髓损伤的研究现状. 实用医学杂志, 2017, 33(1): 10-13.
|
13. |
Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and humanbone marrow stromal cells differentiate into neurons. J Neurosci Res, 2000, 61(4): 364-370.
|
14. |
韩博, 蒋玉东, 董大明, 等. 骨髓间充质干细胞治疗脊髓损伤的研究进展. 中华实用诊断与治疗杂志, 2017, 31(3): 300-302.
|
15. |
Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma, 2011, 28(8): 1611-1682.
|
16. |
Platzbecker U, Prange-Krex G, Bornhäuser M, et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion, 2001, 41(2): 184-189.
|
17. |
Nishio Y, Koda M, Kamada T, et al. Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol, 2007, 66(8): 724-731.
|
18. |
Ha Y, Park HS, Park CW, et al. Synthes Award for Resident Research on Spinal Cord and Spinal Column Injury: granulocyte macrophage colony stimulating factor (GM-CSF) prevents apoptosis and improves functional outcome in experimental spinal cord contusion injury. Clin Neurosurg, 2005, 52: 341-347.
|
19. |
Guo X, Bu X, Li Z, et al. Comparison of autologous bone marrow mononuclear cells transplantation and mobilization by granulocyte colony-stimulating factor in experimental spinal injury. Int J Neurosci, 2012, 122(12): 723-733.
|
20. |
张慧, 郭雨霁, 邴鲁军, 等. 粒细胞集落刺激因子对小鼠急性脊髓损伤的神经保护作用及其机制. 解剖学报, 2012, 43(6): 734-738.
|
21. |
Khorasanizadeh M, Eskian M, Vaccaro AR, et al. Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury. CNS Drugs, 2017, 31(11): 911-937.
|
22. |
Deak E, Seifried E, Henschler R. Homing pathways of mesenchymal stromal cells (MSCs) and their role in clinical applications. Int Rev Immunol, 2010, 29(5): 514-529.
|
23. |
郭卫春, 李军, 熊敏, 等. 基质细胞衍生因子-1/趋化因子受体 4 轴在促红细胞生成素动员骨髓间充质干细胞治疗脊髓损伤中的作用. 中华实验外科杂志, 2015, 32(7): 1506-1509.
|
24. |
Lin L, Lin H, Bai S, et al. Bone marrow mesenchymal stem cells (BMSCs) improved functional recovery of spinal cord injury partly by promoting axonal regeneration. Neurochem Int, 2018, 115: 80-84.
|
25. |
Kadota R, Koda M, Kawabe J, et al. Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats. PLoS One, 2012, 7(11): e50391.
|
26. |
Lee JS, Yang CC, Kuo YM, et al. Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury. Spine (Phila Pa 1976), 2012, 37(1): 10-17.
|
27. |
Chung J, Kim MH, Yoon YJ, et al. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats. J Neurosurg Spine, 2014, 21(6): 966-973.
|
28. |
Okuda A, Horii-Hayashi N, Sasagawa T, et al. Bone marrow stromal cell sheets may promote axonal regeneration and functional recovery with suppression of glial scar formation after spinal cord transection injury in rats. J Neurosurg Spine, 2017, 26(3): 388-395.
|
29. |
Urdziková L, Likavčanová-Mašinová K, Vanĕček V, et al. Flt3 ligand synergizes with granulocyte-colony-stimulating factor in bone marrow mobilization toimprove functional outcome after spinal cord injury in the rat. Cytotherapy, 2011, 13(9): 1090-1104.
|
30. |
Kawabata H, Setoguchi T, Yone K, et al. High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis. Spine (Phila Pa 1976), 2010, 35(11): 1109-1115.
|
31. |
Wu H, Lu D, Jiang H, et al. Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma, 2008, 25(21): 130-139.
|
32. |
Khorasanizadeh M, Eskian M, Vaccaro AR, et al. Granulocyte colony-stimulating factor (G-CSF) for the treatment of spinal cord injury. CNS Drugs, 2017, 31(11): 911-937.
|